We Encourage Investors to Acquire Nyxoah SA (NYXH) Shares - Cantor Fitzgerald Bullish on Stock Following FDA Approval of ACCESS Trial Jul 11, 2022 08:35AM
Cantor Fitzgerald Reiterates Overweight Rating, $34 Price Target on Nyxoah SA (NYXH) Jun 2, 2022 08:44AM